Company research
CASI Pharmaceuticals, Inc.
CIK 1962738Updated Sep 27, 2026
SecurityCASIF · OTC · equity
Historical securities (1)
CASI · NASDAQ · equity · closed Feb 25, 2026Name history
CASI Pharmaceuticals Holdings, Inc. · through Feb 14, 2023
CASIF price & chart
Loading TradingView…
OTC:CASIF on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 25,650,000Source | 53,674,000Source | 75,268,000Source | 96,234,000Source |
| Property, Plant and Equipment, NetUSD | 6,968,000Source | 7,868,000Source | 9,241,000Source | 11,831,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 221,000Source | 238,000Source | 1,839,000Source | 1,063,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 5,632,000Source | 13,468,000Source | 17,083,000Source | 47,112,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 4,092,000Source | 15,345,000Source | 9,551,000Source | 12,973,000Source |
| Inventory, NetUSD | 1,598,000Source | 5,252,000Source | 15,877,000Source | 6,138,000Source |
| Assets, CurrentUSD | 13,457,000Source | 39,576,000Source | 59,344,000Source | 73,423,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 2,135,000Source | 2,888,000Source | 2,560,000Source | 2,975,000Source |
| Operating Lease, Right-of-Use AssetUSD | 2,548,000Source | 3,492,000Source | 2,392,000Source | 1,398,000Source |
| Other Assets, NoncurrentUSD | 740,000Source | 587,000Source | 766,000Source | 1,056,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 62,932,000Source | 51,823,000Source | 51,103,000Source | 29,302,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 2,000Source | 2,000Source | 1,000Source | 1,000Source |
| Additional Paid in CapitalUSD | 722,238,000Source | 713,302,000Source | 695,785,000Source | 691,766,000Source |
| Retained Earnings (Accumulated Deficit)USD | -748,133,000Source | -700,075,000Source | -660,817,000Source | -637,160,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -1,785,000Source | -1,774,000Source | -1,200,000Source | -703,000Source |
| Stockholders' Equity Attributable to ParentUSD | -37,282,000Source | 1,851,000Source | 24,165,000Source | 44,574,000Source |
| Liabilities and EquityUSD | 25,650,000Source | 53,674,000Source | 75,268,000Source | 96,234,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 49,670,000Source | 36,452,000Source | 16,726,000Source | 17,005,000Source |
| Operating Lease, Liability, CurrentUSD | 1,611,000Source | 1,221,000Source | 728,000Source | 868,000Source |
| Accounts Payable, CurrentUSD | 1,065,000Source | 2,723,000Source | 4,438,000Source | 3,289,000Source |
| Operating Lease, Liability, NoncurrentUSD | 1,441,000Source | 2,535,000Source | 1,616,000Source | 476,000Source |
| Other Liabilities, NoncurrentUSD | 13,262,000Source | 15,371,000Source | 15,482,000Source | 12,297,000Source |
| Additional Financial Items | ||||
| Deferred Tax Liabilities, NetUSD | 726,000Source | 937,000Source | 677,000Source | 2,229,000Source |
| Long-term Debt, Current MaturitiesUSD | 19,190,000Source | 18,385,000Source | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | — | — | 18,895,000Source | — |
| Redeemable Noncontrolling Interest, Equity, Common, Carrying AmountUSD | — | — | — | 22,358,000Source |
| Short-term InvestmentsUSD | — | — | 12,011,000Source | 2,763,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -48,058,000Source | -39,258,000Source | -26,259,000Source | -40,257,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 1,200,000Source | 1,300,000Source | 2,500,000Source | 1,200,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 2,986,000Source | 1,306,000Source | 7,217,000Source | 7,010,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -11,253,000Source | 5,794,000Source | -3,422,000Source | 3,170,000Source |
| Increase (Decrease) in InventoriesUSD | -2,505,000Source | -5,828,000Source | 9,739,000Source | 4,231,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -20,754,000Source | -29,224,000Source | -19,967,000Source | -21,088,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 951,000Source | 11,244,000Source | -9,673,000Source | 31,159,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 16,000Source | 223,000Source | 204,000Source | 5,612,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | — | — | 278,000Source | 3,267,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 11,254,000Source | 15,434,000Source | -907,000Source | -3,267,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -7,836,000Source | -3,615,000Source | -30,029,000Source | 8,408,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 4,000Source | — | — | 62,000Source |
| Income Taxes Paid, NetUSD | — | — | 1,807,000Source | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 28,000Source | 1,061,000Source | 1,287,000Source | 1,211,000Source |
| Debt and Equity Securities, Realized Gain (Loss)USD | — | — | -2,009,000Source | — |
| Debt and Equity Securities, Unrealized Gain (Loss)USD | — | — | 35,000Source | 20,000Source |
| Debt Securities, Realized Gain (Loss)USD | — | — | 474,000Source | — |
| DepreciationUSD | 1,229,000Source | 1,270,000Source | — | — |
| Equity Method Investment, Realized Gain (Loss) on DisposalUSD | — | — | — | 5,325,000Source |
| Equity Securities, FV-NI, Gain (Loss)USD | -179,000Source | 1,696,000Source | — | — |
| Equity Securities, FV-NI, Unrealized Gain (Loss)USD | — | -756,000Source | -581,000Source | -8,895,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -2,161,000Source | -192,000Source | 200,000Source | 3,241,000Source |
| Gain (Loss) on Disposition of AssetsUSD | — | 479,000Source | — | -2,058,000Source |
| Gain (Loss) on Disposition of Intangible AssetsUSD | -7,000Source | 479,000Source | — | -2,058,000Source |
| General and Administrative ExpenseUSD | 28,271,000Source | 23,577,000Source | 25,387,000Source | 23,449,000Source |
| Impairment of Intangible Assets, Finite-livedUSD | — | 696,000Source | — | 8,724,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | -2,187,000Source | -1,189,000Source | -48,000Source | -846,000Source |
| Income Tax Expense (Benefit)USD | — | 0Source | -81,000Source | 1,980,000Source |
| Inventory Write-downUSD | 1,149,000Source | 4,797,000Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -48,058,000Source | -39,258,000Source | -26,960,000Source | -41,014,000Source |
| Operating Lease, ExpenseUSD | — | — | — | 1,300,000Source |
| Operating Lease, Lease IncomeUSD | — | 0Source | 0Source | 60,000Source |
| Other Nonoperating Income (Expense)USD | 20,000Source | 188,000Source | 764,000Source | 44,000Source |
| Proceeds from Stock Options ExercisedUSD | 56,000Source | 2,112,000Source | 109,000Source | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | — | 28,537,000Source | 33,879,000Source | 38,047,000Source |
| Cost of RevenueUSD | 10,636,000Source | 17,391,000Source | 13,827,000Source | 15,827,000Source |
| Operating Income (Loss)USD | -45,007,000Source | -39,621,000Source | -25,080,000Source | -34,032,000Source |
| Other Nonoperating Income (Expense)USD | 20,000Source | 188,000Source | 764,000Source | 44,000Source |
| Income Tax Expense (Benefit)USD | — | 0Source | -81,000Source | 1,980,000Source |
| Net Income (Loss) Attributable to ParentUSD | -48,058,000Source | -39,258,000Source | -26,960,000Source | -41,014,000Source |
| Earnings Per Share, BasicUSD per share | -2.59Source | -2.56Source | -2.02Source | -3.01Source |
| Earnings Per Share, DilutedUSD per share | -2.59Source | -2.56Source | -2.02Source | -3.01Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 18,538,046Source | 15,340,277Source | 13,360,185Source | 13,647,455Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 18,538,046Source | 15,340,277Source | 13,360,185Source | 13,647,455Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 28,000Source | 1,061,000Source | 1,287,000Source | 1,211,000Source |
| Costs and ExpensesUSD | 55,083,000Source | 50,767,000Source | 45,132,000Source | 61,312,000Source |
| Debt and Equity Securities, Realized Gain (Loss)USD | — | — | -2,009,000Source | — |
| Debt and Equity Securities, Unrealized Gain (Loss)USD | — | — | 35,000Source | 20,000Source |
| Debt Securities, Realized Gain (Loss)USD | — | — | 474,000Source | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | 2,454,000Source | 1,212,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -2,161,000Source | -192,000Source | 200,000Source | 3,241,000Source |
| General and Administrative ExpenseUSD | 28,271,000Source | 23,577,000Source | 25,387,000Source | 23,449,000Source |
| Gross ProfitUSD | 10,076,000Source | 11,146,000Source | 20,052,000Source | 27,280,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -27,671,000Source | -32,980,000Source | 144,000Source | -12,359,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | -2,187,000Source | -1,189,000Source | -48,000Source | -846,000Source |
| Interest ExpenseUSD | — | — | — | 0Source |
| Interest Income (Expense), NetUSD | — | — | 614,000Source | 127,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | -840,000Source | -871,000Source | — | — |
| Operating Lease, ExpenseUSD | — | — | — | 1,300,000Source |
| Operating Lease, Lease IncomeUSD | — | 0Source | 0Source | 60,000Source |
| Other IncomeUSD | — | 0Source | 0Source | 48,000Source |
| Other Operating IncomeUSD | — | 2,000Source | 6,366,000Source | — |
| Research and Development ExpenseUSD | 6,308,000Source | 8,917,000Source | — | — |
| Selling and Marketing ExpenseUSD | 18,343,000Source | 17,866,000Source | 16,450,000Source | 14,326,000Source |